Related Experiment Video
Updated: Jun 20, 2026

10:08
Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
Published on: November 22, 2024
Platelet function analyzer (PFA-100) offers higher sensitivity and specificity than thromboelastography (TEG) in
Yao-Wen Chang1, Chang-Hui Liao, Yuan-Ji Day
1Transgenic and Molecular Immunogenetics Laboratory, Chang Gung Memorial Hospital, Linkou, Taiwan, R.O.C.
Summary
The platelet function analyzer (PFA-100) is more sensitive and specific than thromboelastography (TEG) for detecting platelet dysfunction and bleeding risk in surgical patients. This finding aids in selecting better diagnostic tools for coagulation abnormalities.
Area of Science:
- Anesthesiology
- Hematology
- Surgical Diagnostics
Background:
- Advanced surgical procedures necessitate early diagnostic techniques for coagulation abnormalities.
- Current methods like thromboelastography (TEG) have limitations in detecting platelet dysfunction.
- Perioperative coagulation and fibrinolysis are critical, yet complex, processes.
Purpose of the Study:
- To compare the sensitivity and specificity of the platelet function analyzer (PFA-100) and TEG.
- To evaluate their efficacy in predicting platelet dysfunction and bleeding risk.
Main Methods:
- Human blood samples from healthy volunteers were analyzed.
- Antiplatelet effects of levobupivacaine and CGS21680 were investigated.
- Measurements included platelet aggregation, PFA-100 closure time, and TEG parameters.
Main Results:
- Levobupivacaine and CGS21680 dose-dependently suppressed platelet aggregation.
- Neither agent significantly altered TEG parameters at maximal doses.
- Both agents significantly prolonged PFA-100 closure time at maximal doses.
Conclusions:
- The PFA-100 demonstrates higher sensitivity and specificity than TEG for detecting platelet dysfunction.
- PFA-100 is a more effective tool for identifying bleeding risks associated with platelet dysfunction.
- This study highlights PFA-100's utility in perioperative coagulation assessment.

